Pura Vida Investments, LLC Cyclerion Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

  • $29.1 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.47 - $1.29 $364,953 - $1 Million
-776,497 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.96 - $1.78 $4,608 - $8,544
4,800 Added 0.62%
776,497 $862,000
Q4 2021

Feb 14, 2022
BUY
$1.56 - $2.99 $545,042 - $1.04 Million
349,386 Added 82.73%
771,697 $1.33 Million
Q3 2021

Nov 15, 2021
SELL
$2.73 - $4.13 $232,535 - $351,785
-85,178 Reduced 16.78%
422,311 $1.3 Million
Q2 2021

Aug 16, 2021
BUY
$2.18 - $4.29 $1.11 Million - $2.18 Million
507,489 New
507,489 $1.98 Million

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0
View Full List

About Cyclerion Therapeutics, Inc.

CYCN Quotes by TradingView
  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $123M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email